Global Neurological Disorder Drugs Market Insights and Forecast to 2026

Global Neurological Disorder Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Neurological Disorder Drugs Product Introduction
1.2 Market Segments
1.3 Key Neurological Disorder Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Neurological Disorder Drugs Market Size Growth Rate by Type
1.4.2 Antipsychotic
1.4.3 Hypnotic & Sedative
1.4.4 Analgesics
1.4.5 Anticoagulants
1.4.6 Others
1.5 Market by Application
1.5.1 Global Neurological Disorder Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Neurological Disorder Drugs Market Size, Estimates and Forecasts
2.1.1 Global Neurological Disorder Drugs Revenue 2015-2026
2.1.2 Global Neurological Disorder Drugs Sales 2015-2026
2.2 Global Neurological Disorder Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Neurological Disorder Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Neurological Disorder Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Neurological Disorder Drugs Competitor Landscape by Players
3.1 Neurological Disorder Drugs Sales by Manufacturers
3.1.1 Neurological Disorder Drugs Sales by Manufacturers (2015-2020)
3.1.2 Neurological Disorder Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Neurological Disorder Drugs Revenue by Manufacturers
3.2.1 Neurological Disorder Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Neurological Disorder Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neurological Disorder Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Neurological Disorder Drugs Revenue in 2019
3.2.5 Global Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Neurological Disorder Drugs Price by Manufacturers
3.4 Neurological Disorder Drugs Manufacturing Base Distribution, Product Types
3.4.1 Neurological Disorder Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neurological Disorder Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Neurological Disorder Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Neurological Disorder Drugs Market Size by Type (2015-2020)
4.1.1 Global Neurological Disorder Drugs Sales by Type (2015-2020)
4.1.2 Global Neurological Disorder Drugs Revenue by Type (2015-2020)
4.1.3 Neurological Disorder Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Neurological Disorder Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Neurological Disorder Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Neurological Disorder Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Neurological Disorder Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Neurological Disorder Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Neurological Disorder Drugs Market Size by Application (2015-2020)
5.1.1 Global Neurological Disorder Drugs Sales by Application (2015-2020)
5.1.2 Global Neurological Disorder Drugs Revenue by Application (2015-2020)
5.1.3 Neurological Disorder Drugs Price by Application (2015-2020)
5.2 Neurological Disorder Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Neurological Disorder Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Neurological Disorder Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Neurological Disorder Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Neurological Disorder Drugs by Country
6.1.1 North America Neurological Disorder Drugs Sales by Country
6.1.2 North America Neurological Disorder Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Neurological Disorder Drugs Market Facts & Figures by Type
6.3 North America Neurological Disorder Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Neurological Disorder Drugs by Country
7.1.1 Europe Neurological Disorder Drugs Sales by Country
7.1.2 Europe Neurological Disorder Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neurological Disorder Drugs Market Facts & Figures by Type
7.3 Europe Neurological Disorder Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Neurological Disorder Drugs by Region
8.1.1 Asia Pacific Neurological Disorder Drugs Sales by Region
8.1.2 Asia Pacific Neurological Disorder Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Neurological Disorder Drugs Market Facts & Figures by Type
8.3 Asia Pacific Neurological Disorder Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Neurological Disorder Drugs by Country
9.1.1 Latin America Neurological Disorder Drugs Sales by Country
9.1.2 Latin America Neurological Disorder Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Neurological Disorder Drugs Market Facts & Figures by Type
9.3 Central & South America Neurological Disorder Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Neurological Disorder Drugs by Country
10.1.1 Middle East and Africa Neurological Disorder Drugs Sales by Country
10.1.2 Middle East and Africa Neurological Disorder Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Neurological Disorder Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Neurological Disorder Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Description and Business Overview
11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis AG Neurological Disorder Drugs Products Offered
11.1.5 Novartis AG Related Developments
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Corporation Information
11.2.2 GlaxoSmithKline plc Description and Business Overview
11.2.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline plc Neurological Disorder Drugs Products Offered
11.2.5 GlaxoSmithKline plc Related Developments
11.3 Merck & Co.
11.3.1 Merck & Co. Corporation Information
11.3.2 Merck & Co. Description and Business Overview
11.3.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck & Co. Neurological Disorder Drugs Products Offered
11.3.5 Merck & Co. Related Developments
11.4 Bayer AG
11.4.1 Bayer AG Corporation Information
11.4.2 Bayer AG Description and Business Overview
11.4.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer AG Neurological Disorder Drugs Products Offered
11.4.5 Bayer AG Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Neurological Disorder Drugs Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Boehringer Ingelheim GmbH
11.6.1 Boehringer Ingelheim GmbH Corporation Information
11.6.2 Boehringer Ingelheim GmbH Description and Business Overview
11.6.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Boehringer Ingelheim GmbH Neurological Disorder Drugs Products Offered
11.6.5 Boehringer Ingelheim GmbH Related Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Corporation Information
11.7.2 Teva Pharmaceutical Description and Business Overview
11.7.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Pharmaceutical Neurological Disorder Drugs Products Offered
11.7.5 Teva Pharmaceutical Related Developments
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Description and Business Overview
11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis AG Neurological Disorder Drugs Products Offered
11.1.5 Novartis AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Neurological Disorder Drugs Market Estimates and Projections by Region
12.1.1 Global Neurological Disorder Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Neurological Disorder Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Neurological Disorder Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Neurological Disorder Drugs Sales Forecast (2021-2026)
12.2.2 North America: Neurological Disorder Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Neurological Disorder Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Neurological Disorder Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Neurological Disorder Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Neurological Disorder Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Neurological Disorder Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Neurological Disorder Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Neurological Disorder Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Neurological Disorder Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Neurological Disorder Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Neurological Disorder Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Neurological Disorder Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Neurological Disorder Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Neurological Disorder Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Neurological Disorder Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Neurological Disorder Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Neurological Disorder Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Neurological Disorder Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Neurological Disorder Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neurological Disorder Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Neurological Disorder Drugs Market Segments
Table 2. Ranking of Global Top Neurological Disorder Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Neurological Disorder Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Antipsychotic
Table 5. Major Manufacturers of Hypnotic & Sedative
Table 6. Major Manufacturers of Analgesics
Table 7. Major Manufacturers of Anticoagulants
Table 8. Major Manufacturers of Others
Table 9. Global Neurological Disorder Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Neurological Disorder Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Neurological Disorder Drugs Sales by Regions 2015-2020 (K Units)
Table 12. Global Neurological Disorder Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Neurological Disorder Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Neurological Disorder Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Neurological Disorder Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Neurological Disorder Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Neurological Disorder Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Disorder Drugs as of 2019)
Table 18. Neurological Disorder Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Neurological Disorder Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Neurological Disorder Drugs Price (2015-2020) (USD/Unit)
Table 21. Neurological Disorder Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Neurological Disorder Drugs Product Type
Table 23. Date of International Manufacturers Enter into Neurological Disorder Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Neurological Disorder Drugs Sales by Type (2015-2020) (K Units)
Table 26. Global Neurological Disorder Drugs Sales Share by Type (2015-2020)
Table 27. Global Neurological Disorder Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Neurological Disorder Drugs Revenue Share by Type (2015-2020)
Table 29. Neurological Disorder Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Neurological Disorder Drugs Sales by Application (2015-2020) (K Units)
Table 31. Global Neurological Disorder Drugs Sales Share by Application (2015-2020)
Table 32. North America Neurological Disorder Drugs Sales by Country (2015-2020) (K Units)
Table 33. North America Neurological Disorder Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Neurological Disorder Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Neurological Disorder Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Neurological Disorder Drugs Sales by Type (2015-2020) (K Units)
Table 37. North America Neurological Disorder Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Neurological Disorder Drugs Sales by Application (2015-2020) (K Units)
Table 39. North America Neurological Disorder Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Neurological Disorder Drugs Sales by Country (2015-2020) (K Units)
Table 41. Europe Neurological Disorder Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Neurological Disorder Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Neurological Disorder Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Neurological Disorder Drugs Sales by Type (2015-2020) (K Units)
Table 45. Europe Neurological Disorder Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Neurological Disorder Drugs Sales by Application (2015-2020) (K Units)
Table 47. Europe Neurological Disorder Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Neurological Disorder Drugs Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Neurological Disorder Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Neurological Disorder Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Neurological Disorder Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Neurological Disorder Drugs Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Neurological Disorder Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Neurological Disorder Drugs Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Neurological Disorder Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Neurological Disorder Drugs Sales by Country (2015-2020) (K Units)
Table 57. Latin America Neurological Disorder Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Neurological Disorder Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Neurological Disorder Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Neurological Disorder Drugs Sales by Type (2015-2020) (K Units)
Table 61. Latin America Neurological Disorder Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Neurological Disorder Drugs Sales by Application (2015-2020) (K Units)
Table 63. Latin America Neurological Disorder Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Neurological Disorder Drugs Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Neurological Disorder Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Neurological Disorder Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Neurological Disorder Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Neurological Disorder Drugs Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Neurological Disorder Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Neurological Disorder Drugs Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Neurological Disorder Drugs Sales Market Share by Application (2015-2020)
Table 72. Novartis AG Corporation Information
Table 73. Novartis AG Description and Major Businesses
Table 74. Novartis AG Neurological Disorder Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Novartis AG Product
Table 76. Novartis AG Recent Development
Table 77. GlaxoSmithKline plc Corporation Information
Table 78. GlaxoSmithKline plc Description and Major Businesses
Table 79. GlaxoSmithKline plc Neurological Disorder Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. GlaxoSmithKline plc Product
Table 81. GlaxoSmithKline plc Recent Development
Table 82. Merck & Co. Corporation Information
Table 83. Merck & Co. Description and Major Businesses
Table 84. Merck & Co. Neurological Disorder Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Merck & Co. Product
Table 86. Merck & Co. Recent Development
Table 87. Bayer AG Corporation Information
Table 88. Bayer AG Description and Major Businesses
Table 89. Bayer AG Neurological Disorder Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Bayer AG Product
Table 91. Bayer AG Recent Development
Table 92. AstraZeneca Corporation Information
Table 93. AstraZeneca Description and Major Businesses
Table 94. AstraZeneca Neurological Disorder Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. AstraZeneca Product
Table 96. AstraZeneca Recent Development
Table 97. Boehringer Ingelheim GmbH Corporation Information
Table 98. Boehringer Ingelheim GmbH Description and Major Businesses
Table 99. Boehringer Ingelheim GmbH Neurological Disorder Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Boehringer Ingelheim GmbH Product
Table 101. Boehringer Ingelheim GmbH Recent Development
Table 102. Teva Pharmaceutical Corporation Information
Table 103. Teva Pharmaceutical Description and Major Businesses
Table 104. Teva Pharmaceutical Neurological Disorder Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Teva Pharmaceutical Product
Table 106. Teva Pharmaceutical Recent Development
Table 107. Global Neurological Disorder Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 108. Global Neurological Disorder Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Neurological Disorder Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Neurological Disorder Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Neurological Disorder Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 112. North America: Neurological Disorder Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Neurological Disorder Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 114. Europe: Neurological Disorder Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Neurological Disorder Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 116. Asia Pacific: Neurological Disorder Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Neurological Disorder Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 118. Latin America: Neurological Disorder Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Neurological Disorder Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 120. Middle East and Africa: Neurological Disorder Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Neurological Disorder Drugs Players
Table 125. Neurological Disorder Drugs Customers List
Table 126. Neurological Disorder Drugs Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurological Disorder Drugs Product Picture
Figure 2. Global Neurological Disorder Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Antipsychotic Product Picture
Figure 4. Hypnotic & Sedative Product Picture
Figure 5. Analgesics Product Picture
Figure 6. Anticoagulants Product Picture
Figure 7. Others Product Picture
Figure 8. Global Neurological Disorder Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Neurological Disorder Drugs Report Years Considered
Figure 12. Global Neurological Disorder Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Neurological Disorder Drugs Sales 2015-2026 (K Units)
Figure 14. Global Neurological Disorder Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Neurological Disorder Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Neurological Disorder Drugs Sales Market Share by Region in 2019
Figure 17. Global Neurological Disorder Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Neurological Disorder Drugs Revenue Market Share by Region in 2019
Figure 19. Global Neurological Disorder Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Neurological Disorder Drugs Revenue in 2019
Figure 21. Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Neurological Disorder Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Neurological Disorder Drugs Sales Market Share by Type in 2019
Figure 24. Global Neurological Disorder Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Neurological Disorder Drugs Revenue Market Share by Type in 2019
Figure 26. Global Neurological Disorder Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Neurological Disorder Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Neurological Disorder Drugs Sales Market Share by Application in 2019
Figure 29. Global Neurological Disorder Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Neurological Disorder Drugs Revenue Market Share by Application in 2019
Figure 31. North America Neurological Disorder Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Neurological Disorder Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Neurological Disorder Drugs Sales Market Share by Country in 2019
Figure 34. North America Neurological Disorder Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Neurological Disorder Drugs Market Share by Type in 2019
Figure 40. North America Neurological Disorder Drugs Market Share by Application in 2019
Figure 41. Europe Neurological Disorder Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Neurological Disorder Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Neurological Disorder Drugs Sales Market Share by Country in 2019
Figure 44. Europe Neurological Disorder Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Neurological Disorder Drugs Market Share by Type in 2019
Figure 56. Europe Neurological Disorder Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Neurological Disorder Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Neurological Disorder Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Neurological Disorder Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Neurological Disorder Drugs Revenue Market Share by Region in 2019
Figure 61. China Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Neurological Disorder Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Neurological Disorder Drugs Market Share by Application in 2019
Figure 85. Latin America Neurological Disorder Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Neurological Disorder Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Neurological Disorder Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Neurological Disorder Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Neurological Disorder Drugs Market Share by Type in 2019
Figure 96. Latin America Neurological Disorder Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Neurological Disorder Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Neurological Disorder Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Neurological Disorder Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Neurological Disorder Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Neurological Disorder Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Neurological Disorder Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Neurological Disorder Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Neurological Disorder Drugs Market Share by Application in 2019
Figure 109. North America Neurological Disorder Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Neurological Disorder Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Neurological Disorder Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Neurological Disorder Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Neurological Disorder Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Neurological Disorder Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Neurological Disorder Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Neurological Disorder Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Neurological Disorder Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Neurological Disorder Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Loratadine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Loratadine market size was valued at US$ 138.8 million in 2023. With growing demand in downstream market, the Loratadine is forecast to a readjusted size of US$ 175.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Loratadine market. Loratadine are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Allergy Rhinitis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Allergy Rhinitis Drugs market: According to our latest research, the global Allergy Rhinitis Drugs market looks promising in the next 5 years. As of 2022, the global Allergy Rhinitis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overrea......

Global Loratadine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Loratadine market: According to our latest research, the global Loratadine market looks promising in the next 5 years. As of 2022, the global Loratadine market was estimated at USD 145.21 million, and it's anticipated to reach USD 210.61 million in 2028, with a CAGR of 6.39% during the forecast years. Loratadine is an antihistamine that reduces the effects of natural chemical histamine on the body. Histamine can produce symptoms of sneezing, itching,......

Global Desloratadine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Desloratadine market: According to our latest research, the global Desloratadine market looks promising in the next 5 years. As of 2022, the global Desloratadine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Desloratadine market, with a sys......

Global Clarityne Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Clarityne market: According to our latest research, the global Clarityne market looks promising in the next 5 years. As of 2022, the global Clarityne market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Clarityne market, with a systematical descri......

Global Allergic Rhinitis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 120

Market Overview of Global Allergic Rhinitis Drugs market: According to our latest research, the global Allergic Rhinitis Drugs market looks promising in the next 5 years. As of 2022, the global Allergic Rhinitis Drugs market was estimated at USD 3956.8 million, and it's anticipated to reach USD 5997.75 million in 2028, with a CAGR of 7.18% during the forecast years. Allergic rhinitis, or hay fever, is an allergic reaction to specific allergens. An allergen is an innocuous sub......

Global Desloratadine Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 107

Belongs to the third generation histamine antagonist of tricyclic long - acting type. It is generally used to relieve the systemic and local symptoms of chronic idiopathic urticaria and perennial allergic rhinitis. The global Desloratadine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Desloratadine is estimated to increase from $ million......

Global Neurological Disorder Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 96

Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson's Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing ris......

Global Allergic Rhinitis Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 125

In individuals with allergic rhinitis, the immune system overreacts and causes an allergic reaction when allergens such as pollen, mold, and dander come in contact with the immune system. The global Allergic Rhinitis Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The Americas accounted for the major shares of the allergy rhinitis drugs market during 2016. In ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs